SL
Sol-Gel Technologies Ltd.
SLGL · NASDAQ
$59.28 +0.47% (+$0.28)
1M -23.40%
Market Cap $193.8M
P/E Ratio -
Div. Yield -
ROE 44.05%
Piotroski F-Score Weak
2/9Valuation
25 /100
Expensive P/B 4.03x
P/S 107.96x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 18.55%
Rev. growth 70.92%
FCF growth N/A
Profitability
22 /100
Weak Net margin 910.14%
Op. margin 986.96%
FCF margin 0.00%
Quality
0 /100
Poor ROE 44.05%
ROA 30.39%
Asset turnover 0.03x
Debt
100 /100
Low Current ratio 10.37x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
19 /100
Unstable Rev. volatility 374.12%
EPS volatility 284.69%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SLGL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Moshe Arkin
Employees
28
Headquarters
Ness Ziona
Prihajajoči dogodki
19 NOV.
Earnings
Upcoming earnings report